Graphite Bio Top Insiders

GRPHDelisted Stock  USD 2.67  0.05  1.84%   
Graphite Bio employs about 6 people. The company is managed by 11 executives with a total tenure of roughly 14 years, averaging almost 1.0 years of service per executive, having 0.55 employees per reported executive. Assessment of Graphite Bio's management performance can provide insight into the firm performance.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Graphite Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.1799) % which means that it has lost $0.1799 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5195) %, meaning that it created substantial loss on money invested by shareholders. Graphite Bio's management efficiency ratios could be used to measure how well Graphite Bio manages its routine affairs as well as how well it operates its assets and liabilities.

Graphite Bio Workforce Comparison

Graphite Bio is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 773. Graphite Bio maintains roughly 6.0 in number of employees contributing less than 1% to equities under Health Care industry.

Graphite Bio Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Graphite Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Graphite Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Graphite Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Graphite Bio Notable Stakeholders

A Graphite Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Graphite Bio often face trade-offs trying to please all of them. Graphite Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Graphite Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kimberlee CPACEO and PresidentidentProfile
Stephanie YaoVice RelationsProfile
Maria MDAcademic BoardProfile
Christine PMPChief OperationsProfile
Jerry CaciaChief OfficerProfile
Philip GutryChief OfficerProfile
Jane GroganChief OfficerProfile
MD FACCCEO PresProfile
Daniel DeverCoFounder ResearchProfile
Alethia YoungChief OfficerProfile
Matthew MDAcademic DirectorProfile

About Graphite Bio Management Performance

The success or failure of an entity such as Graphite Bio often depends on how effective the management is. Graphite Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Graphite management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Graphite management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California. Graphite Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 111 people.

Graphite Bio Workforce Analysis

Traditionally, organizations such as Graphite Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Graphite Bio within its industry.

Graphite Bio Manpower Efficiency

Return on Graphite Bio Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee20.8M
Net Loss Per Executive11.3M
Working Capital Per Employee30.5M
Working Capital Per Executive16.7M
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Graphite Stock

If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital